MitoQ
MitoQ is a dietary supplement with 20 clinical trials. Currently 7 active trials ongoing. Historical success rate of 88.9%.
Success Metrics
Based on 8 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
7
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
72.7%
8 of 11 finished
27.3%
3 ended early
7
trials recruiting
20
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
MARVEL: Mitochondrial Anti-oxidant Therapy to Resolve Inflammation in Ulcerative Colitis
Mini-MARVEL - Mitochondrial Antioxidant Therapy in Ulcerative Colitis
Mitochondrial-targeted Antioxidant Supplementation for Improving Age-related Vascular Dysfunction in Humans
Mitochondria Oxidative Stress and Vascular Health Study
ROAR-DIGAP: A Widely Inclusive, Largely Virtual Pilot Trial Utilizing DIGAP (Deep Integrated Genomics Analysis Platform) To Personalize Treatments
Clinical Trials (20)
MARVEL: Mitochondrial Anti-oxidant Therapy to Resolve Inflammation in Ulcerative Colitis
Mini-MARVEL - Mitochondrial Antioxidant Therapy in Ulcerative Colitis
Mitochondrial-targeted Antioxidant Supplementation for Improving Age-related Vascular Dysfunction in Humans
Mitochondria Oxidative Stress and Vascular Health Study
ROAR-DIGAP: A Widely Inclusive, Largely Virtual Pilot Trial Utilizing DIGAP (Deep Integrated Genomics Analysis Platform) To Personalize Treatments
MitoQ for Early-phase Schizophrenia-spectrum Disorder and Mitochondrial Dysfunction
Effect of MitoQ on Platelet Function and Reactive Oxygen Species Generation in Patients With Sickle Cell Anemia
Impacts of Mitochondrial-targeted Antioxidant on Peripheral Artery Disease Patients
MitoQ and Exercise Effects on Vascular Health
Mitochondrial Derived Reactive Oxygen Species on Cardiovascular Health in Chronic Obstructive Pulmonary Disease (COPD)
Effects of an Antioxidant Supplement on Blood Vessel Health
The Influence of Mitochondrial-Derived Reactive Oxygen Species on Racial Disparities in Neurovascular Function
MitoQ & Cardiopulmonary Responses During Exercise
Effects of Mitochondrial-targeted Antioxidant on Mild Cognitive Impairment (MCI) Patients
Chronic Kidney Disease and Heart Failure With Preserved Ejection Fraction: The Role of Mitochondrial Dysfunction
Mitochondrial Dysfunction and Insulin Resistance in Skeletal Muscle
Concentration of MitoQ in Human Skeletal Muscle
Mitochondrial Oxidative Stress and Vascular Health in Chronic Kidney Disease
The Efficacy of Oral Mitoquinone (MitoQ) Supplementation for Improving Physiological in Middle-aged and Older Adults
A Trial of MitoQ for the Treatment of People With Parkinson's Disease
All 20 trials loaded
Drug Details
- Intervention Type
- DIETARY SUPPLEMENT
- Total Trials
- 20